BRIEF published on 12/11/2024 at 01:40, 11 months 25 days ago Security Concerns Over Chinese-Produced Cellular Radios in the US Wireless Communications Cybersecurity Risks Chinese Radios Haloid Solutions U.S. Law Compliance
BRIEF published on 12/11/2024 at 01:40, 11 months 25 days ago Inquiétudes en matière de sécurité concernant les radios cellulaires fabriquées en Chine aux États-Unis Communications Sans Fil Radios Chinoises Solutions Halogénées Risques De Cybersécurité Conformité À La Législation Américaine
PRESS RELEASE published on 12/11/2024 at 01:35, 11 months 25 days ago Haloid Research Finds that Cellular Walkie Talkies Put Americans at Risk of Chinese Spying Haloid Solutions warns of foreign espionage risks from China-made two-way radios sold by 'pop up companies' in the U.S. Users at risk of spying and legal violations Haloid Solutions Foreign Espionage China-manufactured Radios Pop Up Companies Spying Risks
Published on 12/05/2025 at 02:35, 4 hours 56 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 31 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 26 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 31 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 31 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 41 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 16 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 17 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
